Literature DB >> 4673237

Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).

O D Ratnoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4673237

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  7 in total

1.  Amidolytic properties of single-chain activated Hageman factor.

Authors:  O D Ratnoff; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

2.  Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.

Authors:  O D Ratnoff; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

3.  The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.

Authors:  G H Goldsmith; H Saito; O S Ratnoff
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

4.  Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.

Authors:  H Saito; O D Ratnoff; J S Marshall; J Pensky
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

5.  Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells.

Authors:  K T Schmeidler-Sapiro; O D Ratnoff; E M Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

6.  Inhibition of the activation of Hageman factor (factor XII) by peripheral blood cells.

Authors:  O D Ratnoff; M M Emanuelson; N P Ziats
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

7.  Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin.

Authors:  L W Heck; A P Kaplan
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.